Sex hormones selectively impact the endocervical mucosal microenvironment: Implications for HIV transmission

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Goode, Diana ^a   Aravantinou, Meropi ^a   Jarl, Sebastian ^a   Truong, Rosaline ^a   Derby, Nina ^a   Guerra Perez, Natalia ^a   Kenney, Jessica ^a   Blanchard, James ^b   Gettie, Agegnehu ^c   Robbiani, Melissa ^a   Martinelli, Elena ^a  

^a POPULATION COUNCIL   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA7 INTEGRIN; CD4 ANTIGEN; CELL MARKER; CHEMOKINE RECEPTOR CCR5; ESTRADIOL; HOMING RECEPTOR; INTEGRIN; LIGAND; MEDROXYPROGESTERONE ACETATE; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; SEX HORMONE; SIALOMUCIN; UNCLASSIFIED DRUG; ALPHA4 INTEGRIN; BETA INTEGRIN; BETA7 INTEGRIN; ESTROGEN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MUCIN; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HORMONE ACTION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFECTION SENSITIVITY; MUCOSAL IMMUNITY; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; UTERINE CERVIX MUCOSA; VAGINA; VAGINA DISCHARGE; VIRUS TRANSMISSION; ANIMAL; DRUG EFFECTS; ENDOMETRIUM; GENE EXPRESSION; GENETICS; METABOLISM; MUCOSA; PHYSIOLOGY; TRANSMISSION; UTERINE CERVIX;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CERVIX UTERI; CHEMOKINE CCL21; CHEMOKINE CCL4; ENDOMETRIUM; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION; HIV INFECTIONS; INTEGRIN ALPHA4; INTEGRIN BETA CHAINS; MACACA MULATTA; MEDROXYPROGESTERONE ACETATE; MUCINS; MUCOUS MEMBRANE; RECEPTORS, CCR5;

EID: 84901330071     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097767     Document Type: Article

References (61)

1. Heffron R, Donnell D, Rees H, Celum C, Mugo N, et al. (2012) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 12: 19-26.
2. Baeten JM, Benki S, Chohan V, Lavreys L, McClelland RS, et al. (2007) Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 21: 1771-1777. (Pubitemid 47237565)
3. Morrison CS, Chen PL, Kwok C, Richardson BA, Chipato T, et al. (2010) Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 24: 1778-1781.
4. Lutalo T, Musoke R, Kong X, Makumbi F, Serwadda D, et al. (2013) Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples. AIDS 27 Suppl 1: S27-34.
5. Kiddugavu M, Makumbi F, Wawer MJ, Serwadda D, Sewankambo NK, et al. (2003) Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS 17: 233-240. (Pubitemid 36183050)
6. Wira CR, Fahey JV (2008) A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 22: 1909-1917.
7. Vishwanathan SA, Guenthner PC, Lin CY, Dobard C, Sharma S, et al. (2011) High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J Acquir Immune Defic Syndr 57: 261-264.
8. Hickey DK, Patel MV, Fahey JV, Wira CR (2011) Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 88: 185-194.
9. Wira CR, Rossoll RM, Kaushic C (2000) Antigen-presenting cells in the female reproductive tract: influence of estradiol on antigen presentation by vaginal cells. Endocrinology 141: 2877-2885. (Pubitemid 32250451)
10. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L (2005) Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 206: 306-335. (Pubitemid 41105178)
11. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, et al. (1996) Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 2: 1084-1089. (Pubitemid 26338626)
12. Smith SM, Mefford M, Sodora D, Klase Z, Singh M, et al. (2004) Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. Aids 18: 1637-1643. (Pubitemid 39095780)
13. Smith SM, Baskin GB, Marx PA (2000) Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis 182: 708-715.
14. Shacklett BL, Greenblatt RM (2011) Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications. Am J Reprod Immunol 65: 230-241.
15. Villablanca EJ, Cassani B, von Andrian UH, Mora JR (2011) Blocking lymphocyte localization to the gastrointestinal mucosa as a therapeutic strategy for inflammatory bowel diseases. Gastroenterology 140: 1776-1784.
16. Gorfu G, Rivera-Nieves J, Ley K (2009) Role of beta7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med 9: 836-850.
17. Kelly KA, Natarajan S, Ruther P, Wisse A, Chang MH, et al. (2001) Chlamydia trachomatis infection induces mucosal addressin cell adhesion molecule-1 and vascular cell adhesion molecule-1, providing an immunologic link between the fallopian tube and other mucosal tissues. J Infect Dis 184: 885-891. (Pubitemid 32881093)
18. Kelly KA, Rank RG (1997) Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun 65: 5198-5208. (Pubitemid 27513570)
19. Martinelli E, Tharinger H, Frank I, Arthos J, Piatak M, Jr., et al. (2011) HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. PLoS Pathog 7: e1002109.
20. Kader M, Wang X, Piatak M, Lifson J, Roederer M, et al. (2009) Alpha4(+)beta7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol 2: 439-449.
21. Kader M, Bixler S, Roederer M, Veazey R, Mattapallil JJ (2009) CD4 T cell subsets in the mucosa are CD28+Ki-67-HLA-DR-CD69+ but show differential infection based on alpha4beta7 receptor expression during acute SIV infection. J Med Primatol 38 Suppl 1: 24-31.
22. Cicala C, Martinelli E, McNally JP, Goode DJ, Gopaul R, et al. (2009) The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A 106: 20877-20882.
23. Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, et al. (2008) HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 9: 301-309. (Pubitemid 351267327)
24. Jelicic K, Cimbro R, Nawaz F, Huang da W, Zheng X, et al. (2013) The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-beta1 production and FcRL4 expression. Nat Immunol 14: 1256-1265.
25. Martinelli E, Veglia F, Goode D, Guerra-Perez N, Aravantinou M, et al. (2013) The frequency of alpha4beta7high memory CD4+ T cells correlates with susceptibility to rectal SIV infection. J Acquir Immune Defic Syndr.
26. Mishell DR, Jr. (1996) Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med 41: 381-390.
27. Alvarez Y, Tuen M, Shen G, Nawaz F, Arthos J, et al. (2013) Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands. J Virol 87: 10843-10854.
28. Monteiro P, Gosselin A, Wacleche VS, El-Far M, Said EA, et al. (2011) Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin beta7. J Immunol 186: 4618-4630.
29. Agace WW, Higgins JM, Sadasivan B, Brenner MB, Parker CM (2000) T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEPCAM and chemokines. Curr Opin Cell Biol 12: 563-568.
30. Williams IR (2004) Chemokine receptors and leukocyte trafficking in the mucosal immune system. Immunol Res 29: 283-292.
31. Kawashima H, Fukuda M (2012) Sulfated glycans control lymphocyte homing. Ann N Y Acad Sci 1253: 112-121.
32. Chandra N, Thurman AR, Anderson S, Cunningham TD, Yousefieh N, et al. (2013) Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues. AIDS Res Hum Retroviruses 29: 592-601.
33. Prakash M, Patterson S, Gotch F, Kapembwa MS (2004) Ex vivo analysis of HIV-1 co-receptors at the endocervical mucosa of women using oral contraceptives. BJOG 111: 1468-1470. (Pubitemid 39665044)
34. Kobayashi M, Hoshino H, Suzawa K, Sakai Y, Nakayama J, et al. (2012) Two distinct lymphocyte homing systems involved in the pathogenesis of chronic inflammatory gastrointestinal diseases. Semin Immunopathol 34: 401-413.
35. Arihiro S, Ohtani H, Suzuki M, Murata M, Ejima C, et al. (2002) Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease. Pathol Int 52: 367-374. (Pubitemid 34748219)
36. Hillan KJ, Hagler KE, MacSween RN, Ryan AM, Renz ME, et al. (1999) Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease. Liver 19: 509-518. (Pubitemid 30019065)
37. Szabo MC, Butcher EC, McEvoy LM (1997) Specialization of mucosal follicular dendritic cells revealed by mucosal addressin-cell adhesion molecule-1 display. J Immunol 158: 5584-5588. (Pubitemid 127483959)
38. Leung E, Kanwar RK, Kanwar JR, Krissansen GW (2003) Mucosal vascular addressin cell adhesion molecule-1 is expressed outside the endothelial lineage on fibroblasts and melanoma cells. Immunol Cell Biol 81: 320-327. (Pubitemid 36904340)
39. Leung E, Lehnert KB, Kanwar JR, Yang Y, Mon Y, et al. (2004) Bioassay detects soluble MAdCAM-1 in body fluids. Immunol Cell Biol 82: 400-409. (Pubitemid 39141763)
40. Tal O, Lim HY, Gurevich I, Milo I, Shipony Z, et al. (2011) DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J Exp Med 208: 2141-2153.
41. Campbell DE, Lai JP, Tustin NB, Riedel E, Tustin R, 3rd, et al. (2010) Analytical and biological considerations in the measurement of cell-associated CCR5 and CXCR4 mRNA and protein. Clin Vaccine Immunol 17: 1148-1154.
42. Shukair SA, Allen SA, Cianci GC, Stieh DJ, Anderson MR, et al. (2013) Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol 6: 427-434.
43. Gipson IK (2001) Mucins of the human endocervix. Front Biosci 6: D1245-1255.
44. D'Cruz OJ, Wild RA, Medders DE, Padhye NV, Sachdev GP (1993) Antigenic similarities between respiratory and reproductive tract mucins: heterogeneity of mucin expression by human endocervix and endometrium. Fertil Steril 60: 1011-1019. (Pubitemid 23359487)
45. Genbacev OD, Prakobphol A, Foulk RA, Krtolica AR, Ilic D, et al. (2003) Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface. Science 299: 405-408. (Pubitemid 36120046)
46. Foulk RA, Zdravkovic T, Genbacev O, Prakobphol A (2007) Expression of L-selectin ligand MECA-79 as a predictive marker of human uterine receptivity. J Assist Reprod Genet 24: 316-321. (Pubitemid 47593602)
47. Nejatbakhsh R, Kabir-Salmani M, Dimitriadis E, Hosseini A, Taheripanah R, et al. (2012) Subcellular localization of L-selectin ligand in the endometrium implies a novel function for pinopodes in endometrial receptivity. Reprod Biol Endocrinol 10: 46.
48. Margarit L, Gonzalez D, Lewis PD, Hopkins L, Davies C, et al. (2009) L-selectin ligands in human endometrium: comparison of fertile and infertile subjects. Hum Reprod 24: 2767-2777.
49. Lagow E, DeSouza MM, Carson DD (1999) Mammalian reproductive tract mucins. Hum Reprod Update 5: 280-292. (Pubitemid 29381276)
50. Iqbal SM, Kaul R (2008) Mucosal innate immunity as a determinant of HIV susceptibility. Am J Reprod Immunol 59: 44-54. (Pubitemid 350285582)
51. Zhang ZQ, Wietgrefe SW, Li Q, Shore MD, Duan L, et al. (2004) Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc Natl Acad Sci U S A 101: 5640-5645. (Pubitemid 38481209)
52. Teleshova N, Derby N, Martinelli E, Pugach P, Calenda G, et al. (2013) Simian immunodeficiency virus interactions with macaque dendritic cells. Adv Exp Med Biol 762: 155-181.
53. Brahmbhatt H, Makumbi F, Lutalo T, Sekasanvu J, Serwadda D, et al. (2013) Longitudinal study of correlates of modern contraceptive use and impact of HIV care programmes among HIV concordant and serodiscordant couples in Rakai, Uganda. J Fam Plann Reprod Health Care.
54. Clendenen TV, Koenig KL, Arslan AA, Lukanova A, Berrino F, et al. (2011) Factors associated with inflammation markers, a cross-sectional analysis. Cytokine 56: 769-778.
55. Aisemberg J, Vercelli CA, Bariani MV, Billi SC, Wolfson ML, et al. (2013) Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone. PLoS One 8: e56161.
56. Gipson IK (2005) Human endocervical mucins. Ernst Schering Res Found Workshop: 219-244.
57. Deplancke B, Gaskins HR (2001) Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr 73: 1131S-1141S. (Pubitemid 32496957)
58. Kim YS, Ho SB (2010) Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep 12: 319-330.
59. Kim KC (2012) Role of epithelial mucins during airway infection. Pulm Pharmacol Ther 25: 415-419.
60. Baxter MG, Roberts MT, Gee NA, Lasley BL, Morrison JH, et al. (2013) Multiple clinically relevant hormone therapy regimens fail to improve cognitive function in aged ovariectomized rhesus monkeys. Neurobiol Aging 34: 1882-1890.
61. Sanchez MG, Morissette M, Di Paolo T (2013) Oestradiol modulation of serotonin reuptake transporter and serotonin metabolism in the brain of monkeys. J Neuroendocrinol 25: 560-569.